Tapewire

Nasdaq · USD

PCRX

Pacira BioSciences, Inc.

Export transactions ↓
Tapewire entity
4928
SEC CIK
0001396814
Parsed reports
428

Last 12 months

Inside the activity.

0 purchase rows · 17 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202502
Jan 202601
Feb 202602
Mar 202602
Apr 202604
May 202600
Jun 202602
Jul 202600
Aug 202601
Sep 202600
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 07, 2023 Filed Jun 7, 2023 21:29 UTC
Reinhart Charles A. IIIChief Financial Officer
SaleCommon Stock 1,371 $37.87 $51,912.92
Disclosure

SEC source: 0001209191-23-035261 · doc4.xml · nonDerivative · entry 2

Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,626

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

Read SEC document
June 07, 2023 Filed Jun 8, 2023 01:34 UTC
WILLIAMS KRISTENChief Administrative Officer
SaleCommon Stock 1,357 $37.87 $51,382.81
Disclosure

SEC source: 0001209191-23-035265 · doc4.xml · nonDerivative · entry 2

Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,892

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

Read SEC document
June 07, 2023 Filed Jun 7, 2023 21:33 UTC
STACK DAVID MDirector · CEO and Chairman
SaleCommon Stock 5,326 $37.87 $201,668.99
Disclosure

SEC source: 0001209191-23-035264 · doc4.xml · nonDerivative · entry 2

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 153,781

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

Read SEC document
June 07, 2023 Filed Jun 8, 2023 01:36 UTC
WINSTON ROYChief Medical Officer
SaleCommon Stock 1,857 $37.87 $70,315.31
Disclosure

SEC source: 0001209191-23-035266 · doc4.xml · nonDerivative · entry 2

WINSTON ROY · CIK 0001751757 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,356

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

Read SEC document
June 07, 2023 Filed Jun 8, 2023 01:31 UTC
RIKER LAURENSenior Vice President, Finance
SaleCommon Stock 616 $37.87 $23,324.84
Disclosure

SEC source: 0001209191-23-035262 · doc4.xml · nonDerivative · entry 2

Riker Lauren Bullaro · CIK 0001545439 · Senior Vice President, Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,053

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

Read SEC document
June 07, 2023 Filed Jun 8, 2023 01:28 UTC
REINHARDT MAXPresident, Rest of World
SaleCommon Stock 1,099 $37.87 $41,613.64
Disclosure

SEC source: 0001209191-23-035260 · doc4.xml · nonDerivative · entry 2

REINHARDT MAX · CIK 0001780058 · President, Rest of World

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,225

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

Read SEC document
June 07, 2023 Filed Jun 8, 2023 01:24 UTC
McLoughlin DennisChief Customer Officer
SaleCommon Stock 1,057 $37.87 $40,023.31
Disclosure

SEC source: 0001209191-23-035258 · doc4.xml · nonDerivative · entry 2

McLoughlin Dennis · CIK 0001752004 · Chief Customer Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,115

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

Read SEC document
June 07, 2023 Filed Jun 8, 2023 01:22 UTC
GAUGLER DARYLChief Operating Officer
SaleCommon Stock 1,047 $37.87 $39,644.66
Disclosure

SEC source: 0001209191-23-035256 · doc4.xml · nonDerivative · entry 3

GAUGLER DARYL · CIK 0001928278 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,539

F2 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

Read SEC document
June 07, 2023 Filed Jun 8, 2023 01:20 UTC
Ellis Ronald J. Jr.Chief Strategy Officer
SaleCommon Stock 1,162 $37.87 $43,999.13
Disclosure

SEC source: 0001209191-23-035255 · doc4.xml · nonDerivative · entry 2

Ellis Ronald J. Jr. · CIK 0001790670 · Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,909

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 01:32 UTC
SLONIN JONATHANChief Clinical Officer
SaleCommon Stock 471 $38.99 $18,364.76
Disclosure

SEC source: 0001209191-23-035263 · doc4.xml · nonDerivative · entry 1

SLONIN JONATHAN · CIK 0001875723 · Chief Clinical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,813

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

F2 · balance_after: Includes 205 shares of common stock acquired under the issuer's employee stock purchase plan in December 2022.

Read SEC document
June 06, 2023 Filed Jun 7, 2023 21:29 UTC
Reinhart Charles A. IIIChief Financial Officer
SaleCommon Stock 1,236 $38.99 $48,192.88
Disclosure

SEC source: 0001209191-23-035261 · doc4.xml · nonDerivative · entry 1

Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,997

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 01:34 UTC
WILLIAMS KRISTENChief Administrative Officer
SaleCommon Stock 1,301 $38.99 $50,727.29
Disclosure

SEC source: 0001209191-23-035265 · doc4.xml · nonDerivative · entry 1

Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,249

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

Read SEC document
June 06, 2023 Filed Jun 7, 2023 21:33 UTC
STACK DAVID MDirector · CEO and Chairman
SaleCommon Stock 5,058 $38.99 $197,216.48
Disclosure

SEC source: 0001209191-23-035264 · doc4.xml · nonDerivative · entry 1

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 159,107

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

F2 · balance_after: Includes an aggregate of 414 shares of common stock acquired under the issuer's employee stock purchase plan in June 2022 and December 2022.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 01:36 UTC
WINSTON ROYChief Medical Officer
SaleCommon Stock 1,779 $38.99 $69,364.99
Disclosure

SEC source: 0001209191-23-035266 · doc4.xml · nonDerivative · entry 1

WINSTON ROY · CIK 0001751757 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,213

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 01:31 UTC
RIKER LAURENSenior Vice President, Finance
SaleCommon Stock 591 $38.99 $23,043.68
Disclosure

SEC source: 0001209191-23-035262 · doc4.xml · nonDerivative · entry 1

Riker Lauren Bullaro · CIK 0001545439 · Senior Vice President, Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,669

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

F2 · balance_after: Includes 408 shares of common stock acquired under the issuer's employee stock purchase plan in June 2022.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 01:28 UTC
REINHARDT MAXPresident, Rest of World
SaleCommon Stock 1,054 $38.99 $41,096.51
Disclosure

SEC source: 0001209191-23-035260 · doc4.xml · nonDerivative · entry 1

REINHARDT MAX · CIK 0001780058 · President, Rest of World

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,324

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 01:26 UTC
MOLLOY ANTHONYChief Lgl & Compliance Officer
SaleCommon Stock 4,521 $38.55 $174,284.55
Disclosure

SEC source: 0001209191-23-035259 · doc4.xml · nonDerivative · entry 2

MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,877

F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 01:24 UTC
McLoughlin DennisChief Customer Officer
SaleCommon Stock 1,014 $38.99 $39,536.87
Disclosure

SEC source: 0001209191-23-035258 · doc4.xml · nonDerivative · entry 1

McLoughlin Dennis · CIK 0001752004 · Chief Customer Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,172

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

F2 · balance_after: Includes an aggregate of 416 shares of common stock acquired under the issuer's employee stock purchase plan in June 2022 and December 2022.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 01:22 UTC
GAUGLER DARYLChief Operating Officer
SaleCommon Stock 1,005 $38.99 $39,185.96
Disclosure

SEC source: 0001209191-23-035256 · doc4.xml · nonDerivative · entry 2

GAUGLER DARYL · CIK 0001928278 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,586

F2 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 01:20 UTC
Ellis Ronald J. Jr.Chief Strategy Officer
SaleCommon Stock 1,114 $38.99 $43,435.97
Disclosure

SEC source: 0001209191-23-035255 · doc4.xml · nonDerivative · entry 1

Ellis Ronald J. Jr. · CIK 0001790670 · Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,071

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

Read SEC document
June 05, 2023 Filed Jun 8, 2023 01:23 UTC SaleCommon Stock 580 $38.34 $22,236.62
Disclosure

SEC source: 0001209191-23-035257 · doc4.xml · nonDerivative · entry 1

HASTINGS PAUL J · CIK 0001309702 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,599

Read SEC document
June 05, 2023 Filed Jun 8, 2023 01:18 UTC
Brege LauraDirector
SaleCommon Stock 600 $38.74 $23,244.00
Disclosure

SEC source: 0001209191-23-035254 · doc4.xml · nonDerivative · entry 1

Brege Laura · CIK 0001365619 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,547

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
June 05, 2023 Filed Jun 8, 2023 01:26 UTC
MOLLOY ANTHONYChief Lgl & Compliance Officer
SaleCommon Stock 2,267 $38.28 $86,773.96
Disclosure

SEC source: 0001209191-23-035259 · doc4.xml · nonDerivative · entry 1

MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,398

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

F2 · balance_after: Includes 215 shares of common stock acquired under the issuer's employee stock purchase plan in June 2022.

Read SEC document
June 05, 2023 Filed Jun 8, 2023 01:22 UTC
GAUGLER DARYLChief Operating Officer
SaleCommon Stock 1,000 $38.74 $38,740.00
Disclosure

SEC source: 0001209191-23-035256 · doc4.xml · nonDerivative · entry 1

GAUGLER DARYL · CIK 0001928278 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 23,591

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
May 31, 2023 Filed Jun 2, 2023 22:28 UTC
GAUGLER DARYLChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 2,500 $0.00 Strike: $34.00 $0.00
Disclosure

SEC source: 0001209191-23-033985 · doc4.xml · derivative · entry 3

GAUGLER DARYL · CIK 0001928278 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,500 shares

Expires 2023-06-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F3 · derivative.exercise_date: The stock option vested in equal monthly installments over one year following the grant date, provided that the reporting person remained in continuous service with the issuer as of each vesting date.

Read SEC document
May 31, 2023 Filed Jun 2, 2023 22:28 UTC
GAUGLER DARYLChief Operating Officer
SaleCommon Stock 2,500 $39.08 $97,700.00
Disclosure

SEC source: 0001209191-23-033985 · doc4.xml · nonDerivative · entry 2

GAUGLER DARYL · CIK 0001928278 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,591

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F2 · balance_after: Includes an aggregate of 197 shares of common stock acquired under the issuer's employee stock purchase plan in June 2022 and December 2022.

Read SEC document
May 31, 2023 Filed Jun 2, 2023 22:28 UTC
GAUGLER DARYLChief Operating Officer
Exercise / conversionCommon Stock 2,500 $34.00 $85,000.00
Disclosure

SEC source: 0001209191-23-033985 · doc4.xml · nonDerivative · entry 1

GAUGLER DARYL · CIK 0001928278 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,894

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
May 15, 2023 Filed May 17, 2023 20:07 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 7,000 $0.00 Strike: $29.90 $0.00
Disclosure

SEC source: 0001209191-23-030141 · doc4.xml · derivative · entry 3

HASTINGS PAUL J · CIK 0001309702 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,000 shares

Expires 2023-06-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F2 · derivative.exercise_date: The stock option vested and became exercisable in twelve equal monthly installments, with the first installment being on July 12, 2013.

Read SEC document
May 15, 2023 Filed May 17, 2023 20:07 UTC SaleCommon Stock 7,000 $41.85 $292,950.00
Disclosure

SEC source: 0001209191-23-030141 · doc4.xml · nonDerivative · entry 2

HASTINGS PAUL J · CIK 0001309702 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,179

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
May 15, 2023 Filed May 17, 2023 20:07 UTC Exercise / conversionCommon Stock 7,000 $29.90 $209,300.00
Disclosure

SEC source: 0001209191-23-030141 · doc4.xml · nonDerivative · entry 1

HASTINGS PAUL J · CIK 0001309702 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,179

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
May 11, 2023 Filed May 15, 2023 22:53 UTC
PACE GARY WDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 7,000 $0.00 Strike: $29.90 $0.00
Disclosure

SEC source: 0001209191-23-029616 · doc4.xml · derivative · entry 3

PACE GARY W · CIK 0001184778 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,000 shares

Expires 2023-06-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option vested and became exercisable in twelve equal monthly installments, with the first installment being on July 12, 2013.

Read SEC document
May 11, 2023 Filed May 15, 2023 22:53 UTC
PACE GARY WDirector
SaleCommon Stock 5,015 $41.78 $209,526.70
Disclosure

SEC source: 0001209191-23-029616 · doc4.xml · nonDerivative · entry 2

PACE GARY W · CIK 0001184778 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 139,675

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.75 to $41.85, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
May 11, 2023 Filed May 15, 2023 22:53 UTC
PACE GARY WDirector
Exercise / conversionCommon Stock 7,000 $29.90 $209,300.00
Disclosure

SEC source: 0001209191-23-029616 · doc4.xml · nonDerivative · entry 1

PACE GARY W · CIK 0001184778 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144,690

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 20:34 UTC
Brege LauraDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 7,000 $0.00 Strike: $29.90 $0.00
Disclosure

SEC source: 0001209191-23-023336 · doc4.xml · derivative · entry 3

Brege Laura · CIK 0001365619 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,000 shares

Expires 2023-06-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F2 · derivative.exercise_date: The option vested in 12 equal monthly installments, provided that the reporting person remained in continuous service with the issuer through each vesting date, and became fully exercisable on June 12, 2014.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 20:34 UTC
Brege LauraDirector
SaleCommon Stock 7,000 $40.72 $285,040.00
Disclosure

SEC source: 0001209191-23-023336 · doc4.xml · nonDerivative · entry 2

Brege Laura · CIK 0001365619 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,147

F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 20:34 UTC
Brege LauraDirector
Exercise / conversionCommon Stock 7,000 $29.90 $209,300.00
Disclosure

SEC source: 0001209191-23-023336 · doc4.xml · nonDerivative · entry 1

Brege Laura · CIK 0001365619 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,147

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
January 05, 2023 Filed Jan 7, 2023 00:04 UTC
MOLLOY ANTHONYChief Lgl & Compliance Officer
SaleCommon Stock 546 $38.31 $20,917.26
Disclosure

SEC source: 0001209191-23-002474 · doc4.xml · nonDerivative · entry 2

MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,450

F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
January 04, 2023 Filed Jan 7, 2023 00:04 UTC
MOLLOY ANTHONYChief Lgl & Compliance Officer
SaleCommon Stock 158 $39.09 $6,176.69
Disclosure

SEC source: 0001209191-23-002474 · doc4.xml · nonDerivative · entry 1

MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,996

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

F2 · balance_after: Includes 204 shares of common stock acquired under the issuer's employee stock purchase plan in December 2022.

Read SEC document
October 07, 2022 Filed Oct 11, 2022 20:13 UTC
REINHARDT MAXPresident, Rest of World
SaleCommon Stock 1,380 $58.00 $80,040.00
Disclosure

SEC source: 0001209191-22-053275 · doc4.xml · nonDerivative · entry 1

REINHARDT MAX · CIK 0001780058 · President, Rest of World

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,378

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F2 · balance_after: Includes 408 shares of common stock acquired under the issuer's employee stock purchase plan in June 2022.

Read SEC document
August 03, 2022 Filed Aug 5, 2022 20:04 UTC
SLONIN JONATHANChief Clinical Officer
SaleCommon Stock 308 $55.70 $17,155.60
Disclosure

SEC source: 0001209191-22-044554 · doc4.xml · nonDerivative · entry 1

SLONIN JONATHAN · CIK 0001875723 · Chief Clinical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,079

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

Read SEC document
August 03, 2022 Filed Aug 5, 2022 20:06 UTC
WINSTON ROYChief Medical Officer
SaleCommon Stock 476 $55.70 $26,513.20
Disclosure

SEC source: 0001209191-22-044560 · doc4.xml · nonDerivative · entry 1

WINSTON ROY · CIK 0001751757 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,992

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

F2 · balance_after: Includes 408 shares of common stock acquired under the issuer's employee stock purchase plan in June 2022.

Read SEC document
July 11, 2022 Filed Jul 13, 2022 20:03 UTC SaleCommon Stock 533 $56.95 $30,354.35
Disclosure

SEC source: 0001209191-22-042037 · doc4.xml · nonDerivative · entry 1

HASTINGS PAUL J · CIK 0001309702 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,179

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F2 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

Read SEC document
July 05, 2022 Filed Jul 7, 2022 23:04 UTC
SLONIN JONATHANChief Clinical Officer
SaleCommon Stock 924 $57.19 $52,841.71
Disclosure

SEC source: 0001209191-22-041521 · doc4.xml · nonDerivative · entry 1

SLONIN JONATHAN · CIK 0001875723 · Chief Clinical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,387

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

F2 · balance_after: Includes 214 shares of common stock acquired under the issuer's employee stock purchase plan in June 2022.

Read SEC document
June 14, 2022 Filed Jun 16, 2022 20:05 UTC
LARANJEIRA CHARLES ANTHONYChief Technical Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 6,000 $0.00 Strike: $38.35 $0.00
Disclosure

SEC source: 0001209191-22-037399 · doc4.xml · derivative · entry 2

LARANJEIRA CHARLES ANTHONY · CIK 0001524338 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,000

Underlying: Common Stock · 6,000 shares

Expires 2028-06-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
June 14, 2022 Filed Jun 16, 2022 20:05 UTC
LARANJEIRA CHARLES ANTHONYChief Technical Officer
Exercise / conversionCommon Stock 6,000 $38.35 $230,100.00
Disclosure

SEC source: 0001209191-22-037399 · doc4.xml · nonDerivative · entry 1

LARANJEIRA CHARLES ANTHONY · CIK 0001524338 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,752

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 23:45 UTC
SLONIN JONATHANChief Clinical Officer
SaleStock Option (Right to Buy) · Derivative 24,800 $0.00 Strike: $59.39 $0.00
Disclosure

SEC source: 0001209191-22-035232 · doc4.xml · derivative · entry 3

SLONIN JONATHAN · CIK 0001875723 · Chief Clinical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,800

Underlying: Common Stock · 24,800 shares

Expires 2032-06-08

F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 23:45 UTC
SLONIN JONATHANChief Clinical Officer
GrantCommon Stock 9,900 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-035232 · doc4.xml · nonDerivative · entry 2

SLONIN JONATHAN · CIK 0001875723 · Chief Clinical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,097

F2 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2023, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 19:22 UTC GrantStock Option (Right to Buy) · Derivative 8,225 $0.00 Strike: $59.39 $0.00
Disclosure

SEC source: 0001209191-22-035218 · doc4.xml · derivative · entry 2

Froimson Mark · CIK 0001709050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,225

Underlying: Common Stock · 8,225 shares

Expires 2032-06-08

Read SEC document
June 08, 2022 Filed Jun 8, 2022 19:22 UTC GrantCommon Stock 1,160 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-035218 · doc4.xml · nonDerivative · entry 1

Froimson Mark · CIK 0001709050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,068

F1 · shares: Represents restricted stock units that vest on June 3, 2023, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 19:41 UTC
Reinhart Charles A. IIIChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 19,900 $0.00 Strike: $59.39 $0.00
Disclosure

SEC source: 0001209191-22-035230 · doc4.xml · derivative · entry 3

Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,900

Underlying: Common Stock · 19,900 shares

Expires 2032-06-08

F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.